Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 7:2020:4592450.
doi: 10.1155/2020/4592450. eCollection 2020.

Pregnancy and Neonatal Outcomes in SARS-CoV-2 Infection: A Systematic Review

Reem S Chamseddine  1 , Farah Wahbeh  1 , Frank Chervenak  2 , Laurent J Salomon  3 , Baderledeen Ahmed  4   5 , Arash Rafii  1   6
Affiliations

Pregnancy and Neonatal Outcomes in SARS-CoV-2 Infection: A Systematic Review

Reem S Chamseddine et al. J Pregnancy. .

Abstract

With the emergence of SARS-CoV-2 and its rapid spread, concerns regarding its effects on pregnancy outcomes have been growing. We reviewed 245 pregnancies complicated by maternal SARS-CoV-2 infection across 48 studies listed on PubMed and MedRxiv. The most common clinical presentations were fever (55.9%), cough (36.3%), fatigue (11.4%), and dyspnea (12.7%). Only 4.1% of patients developed respiratory distress. Of all patients, 89.0% delivered via cesarean section (n = 201), with a 33.3% rate of gestational complications, a 35.3% rate of preterm delivery, and a concerning 2.5% rate of stillbirth delivery or neonatal death. Among those tested, 6.45% of newborns were reported positive for SARS-CoV-2 infection. Relative to known viral infections, the prognosis for pregnant women with SARS-CoV-2 is good, even in the absence of specific antiviral treatment. However, neonates and acute patients, especially those with gestational or preexisting comorbidities, must be actively managed to prevent the severe outcomes being increasingly reported in the literature.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interests.

Figures

Figure 1
Figure 1
Search strategy flowchart.
See this image and copyright information in PMC

References

    1. Mertz D., Geraci J., Winkup J., Gessner B. D., Ortiz J. R., Loeb M. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine. 2017;35(4):521–528. doi: 10.1016/j.vaccine.2016.12.012. - DOI - PMC - PubMed
    1. Racicot K., Mor G. Risks associated with viral infections during pregnancy. The Journal of Clinical Investigation. 2017;127(5):1591–1599. doi: 10.1172/JCI87490. - DOI - PMC - PubMed
    1. Ribeiro A. F., Pellini A. C. G., Kitagawa B. Y., et al. Severe influenza A(H1N1)pdm09 in pregnant women and neonatal outcomes, State of Sao Paulo, Brazil, 2009. PLoS One. 2018;13(3, article e0194392) doi: 10.1371/journal.pone.0194392. - DOI - PMC - PubMed
    1. Fell D. B., Savitz D. A., Kramer M. S., et al. Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG: An International Journal of Obstetrics & Gynaecology. 2017;124(1):48–59. doi: 10.1111/1471-0528.14143. - DOI - PMC - PubMed
    1. Chu H. Y., Katz J., Tielsch J., et al. Clinical presentation and birth outcomes associated with respiratory syncytial virus infection in pregnancy. PLoS One. 2016;11(3):p. e0152015. doi: 10.1371/journal.pone.0152015. - DOI - PMC - PubMed

Publication types